STAT Plus: Pharmalittle: Moderna executives cashed out big time; should we have ‘quality scores’ for manufacturing drugs?
A group of academics and pharmacists argue that assigning scores based on a mix of regulatory actions and chemical analysis would motivate drug makers to produce more “quality” drugs.
by Ed Silverman
May 27, 2020
1 minute
Hello, everyone, and how are you today? We are coping so far, thank you. Despite gray skies hovering over the Pharmalot
You’re reading a preview, subscribe to read more.
Start your free 30 days